Philips cuts 2025 profit margin outlook as U.S. tariffs threaten earnings

Published 06/05/2025, 07:24

Investing.com -- Philips (AS:PHG) on Tuesday lowered its profit margin forecast for 2025, citing a financial hit from anticipated U.S. tariffs on Chinese imports. 

The Dutch health technology company now expects its adjusted EBITA margin to fall within the range of 10.8% to 11.3%, down from its previous guidance of 11.8% to 12.3%.

Philips estimates the net impact of the tariffs will be between €250 million and €300 million, despite efforts to mitigate the blow through relief measures and exemptions such as those outlined in the Nairobi Protocol, which provides tariff relief for certain medical devices used to treat chronic conditions.

CEO Roy Jakobs acknowledged the uncertainty surrounding the evolving tariff landscape, saying, “In an uncertain macro environment that has intensified due to the potential impact of tariffs, we are focused on what we can control.”

Despite the margin downgrade, Philips reported better-than-expected first-quarter results. 

Sales for Q1 came in at €4.10 billion, down 2% year-on-year on a comparable basis, but ahead of the consensus estimate of €4.02 billion. A strong performance in North America helped offset weaker results in China.

The company maintained its guidance for full-year comparable sales growth of 1% to 3%, maintaining a cautious but steady outlook amid global economic headwinds.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.